Mitochondrial adenosine triphosphate production

Mitochondrial adenosine triphosphate (ATP) production refers to the cellular process by which mitochondria generate ATP, the primary energy currency in cells. This occurs through oxidative phosphorylation, where electrons from NADH and FADH₂ are transferred along the electron transport chain embedded in the inner mitochondrial membrane. The movement of electrons drives proton pumps that create an electrochemical gradient across this membrane. Protons flow back into the matrix through ATP synthase, an enzyme complex that uses this proton motive force to catalyze the conversion of ADP and inorganic phosphate into ATP[1][3][5][7]. Oxygen acts as the final electron acceptor at the end of this chain. This process is essential for nearly all eukaryotic life forms because it provides most cellular ATP required for metabolism, biosynthesis, active transport, muscle contraction, neuronal activity, and other vital functions[5]. Dysfunctional mitochondrial ATP synthesis is associated with numerous diseases—including neurodegenerative conditions like Parkinson’s disease—and can result from genetic mutations affecting components such as those seen in Wilson's or Gaucher disease[2][4]. Note: "Mitochondrial adenosine triphosphate production" describes a biological *process*, not a discrete molecular target such as an enzyme or receptor. Therefore it does not fit standard definitions used for drug targets; instead, individual proteins within this pathway—like ATP synthase or complexes I-IV—are considered therapeutic targets. For structured data purposes regarding drug discovery databases focused on molecular targets rather than processes, this entry should be flagged as incorrect ("is_incorrect": true).

Other names

Mitochondrial ATP productionOxidative phosphorylation (process)Chemiosmosis (process)